SI-BONE Inc. (SIBN)
SI-BONE Statistics
Share Statistics
SI-BONE has 42.45M shares outstanding. The number of shares has increased by 2.13% in one year.
Shares Outstanding | 42.45M |
Shares Change (YoY) | 2.13% |
Shares Change (QoQ) | 0.59% |
Owned by Institutions (%) | 97.6% |
Shares Floating | 36.89M |
Failed to Deliver (FTD) Shares | 294 |
FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 1.13M, so 2.69% of the outstanding shares have been sold short.
Short Interest | 1.13M |
Short % of Shares Out | 2.69% |
Short % of Float | 3.06% |
Short Ratio (days to cover) | 3.43 |
Valuation Ratios
The PE ratio is -18.81 and the forward PE ratio is -26.51. SI-BONE's PEG ratio is 0.56.
PE Ratio | -18.81 |
Forward PE | -26.51 |
PS Ratio | 3.48 |
Forward PS | 2.9 |
PB Ratio | 3.48 |
P/FCF Ratio | -25.36 |
PEG Ratio | 0.56 |
Enterprise Valuation
SI-BONE Inc. has an Enterprise Value (EV) of 812.31M.
EV / Earnings | -26.28 |
EV / Sales | 4.86 |
EV / EBITDA | -35.17 |
EV / EBIT | -23.05 |
EV / FCF | -35.44 |
Financial Position
The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.01.
Current Ratio | 7.66 |
Quick Ratio | 6.66 |
Debt / Equity | 0.01 |
Total Debt / Capitalization | 1.2 |
Cash Flow / Debt | -6.12 |
Interest Coverage | -10.25 |
Financial Efficiency
Return on equity (ROE) is -0.19% and return on capital (ROIC) is -20.86%.
Return on Equity (ROE) | -0.19% |
Return on Assets (ROA) | -0.13% |
Return on Capital (ROIC) | -20.86% |
Revenue Per Employee | $479,020.06 |
Profits Per Employee | $-88,575.93 |
Employee Count | 349 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.29 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -1.41% in the last 52 weeks. The beta is 1.17, so SI-BONE's price volatility has been higher than the market average.
Beta | 1.17 |
52-Week Price Change | -1.41% |
50-Day Moving Average | 16.04 |
200-Day Moving Average | 14.6 |
Relative Strength Index (RSI) | 53.88 |
Average Volume (20 Days) | 356.08K |
Income Statement
In the last 12 months, SI-BONE had revenue of 167.18M and earned -30.91M in profits. Earnings per share was -0.75.
Revenue | 167.18M |
Gross Profit | 132.12M |
Operating Income | -35.25M |
Net Income | -30.91M |
EBITDA | -23.09M |
EBIT | -35.25M |
Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 34.95M in cash and 2.03M in debt, giving a net cash position of 32.92M.
Cash & Cash Equivalents | 34.95M |
Total Debt | 2.03M |
Net Cash | 32.92M |
Retained Earnings | -431.35M |
Total Assets | 230.44M |
Working Capital | 180.65M |
Cash Flow
In the last 12 months, operating cash flow was -12.43M and capital expenditures -10.5M, giving a free cash flow of -22.92M.
Operating Cash Flow | -12.43M |
Capital Expenditures | -10.5M |
Free Cash Flow | -22.92M |
FCF Per Share | -0.55 |
Margins
Gross margin is 79.03%, with operating and profit margins of -21.08% and -18.49%.
Gross Margin | 79.03% |
Operating Margin | -21.08% |
Pretax Margin | -18.49% |
Profit Margin | -18.49% |
EBITDA Margin | -13.81% |
EBIT Margin | -21.08% |
FCF Margin | -13.71% |
Dividends & Yields
SIBN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -4.28% |
FCF Yield | -3.08% |
Analyst Forecast
The average price target for SIBN is $25, which is 42.6% higher than the current price. The consensus rating is "Buy".
Price Target | $25 |
Price Target Difference | 42.6% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Scores
Altman Z-Score | 5.71 |
Piotroski F-Score | 2 |